Trials / Completed
CompletedNCT01496261
Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
Comparative Pharmacokinetics of Clopidogrel 75mg and Aspirin 100mg After Single Oral Administration as a Fixed Dose Combination Versus Separate Combination in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare pharmacokinetics between fixed-dose combination and separate combination of clopidogrel 75mg/aspirin 100mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clopidogrel and Aspirin | Clopidogrel and Aspirin seperate combination, single dose |
| DRUG | Fixed dose combination of clopidogrel/aspirin | Fixed dose combination of clopidogrel/aspirin |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-12-21
- Last updated
- 2011-12-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01496261. Inclusion in this directory is not an endorsement.